Gossamer Bio (GOSS) EPS (Basic) Growth (5y) (2023 - 2026)
Gossamer Bio (GOSS) EPS (Basic) Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - |
| 10 | Gossamer Bio | 48.99 Mn | -8.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.74% |
| Mar 31, 2026 | 22.80% |
| Dec 31, 2025 | 25.00% |
| Sep 30, 2025 | 23.34% |
| Jun 30, 2025 | 33.57% |
| Mar 31, 2025 | 27.68% |
| Dec 31, 2024 | 32.48% |
| Sep 30, 2024 | 38.51% |
| Jun 30, 2024 | 16.07% |
| Mar 31, 2024 | 41.67% |
| Dec 31, 2023 | 48.46% |
| Sep 30, 2023 | 51.53% |
| Jun 30, 2023 | 39.95% |
| Mar 31, 2023 | 34.63% |